News

Early career researchers Dr Stacey Ellery and Ms Aya Mousa have won the MHTP Research Week ECR speed networking event, receiving a $10,000 grant to progress their research idea.…  Read more

Uncovering how abnormal immune cell populations in the womb could be linked to repeat implantation failure and early pregnancy loss is the focus of new research by Dr Ellen Menkhorst. Dr Menkhorst, a Research Scientist in the Embryo Implantation Research Group, has been awarded a $100,000 grant from the Rebecca L. Cooper Foundation to help…  Read more

Scientists at Hudson Institute of Medical Research have identified a family of genes that could more accurately detect stomach cancer in its early stages to help improve survival rates. Stomach or gastric cancer is the third leading cause of cancer death worldwide. It is caused by the abnormal growth of cells in the lining, or…  Read more

Hudson Institute of Medical Research scientists are combining stem cells from the lining of a woman’s own uterus with nanobiomaterials (biodegradable materials engineered on the nanoscale) in a world-first approach to develop safer, more effective treatments for pelvic organ prolapse.…  Read more

Premature and full-term babies who do not require respiratory support may benefit from leaving their umbilical cord unclamped for at least 60 seconds after birth, according to the authors of a Perspective published by the Medical Journal of Australia.…  Read more

Discovering new treatments to repair damage to nerve cells caused by Multiple Sclerosis (MS) will be the focus of research at Hudson Institute of Medical Research, thanks to funding from MS Research Australia. Dr Claire McCoy has been awarded a $25,000 MS Research Australia incubator grant to progress her research into the role of macrophages,…  Read more

La Trobe University and Hudson Institute of Medical Research are leading pioneering research aimed at understanding infertility and improving the rate of assisted and natural pregnancies – an approach that may lead to ‘personalised IVF’. The team, led by Dr David Greening from La Trobe Institute for Molecular Science and Professor Lois Salamonsen from Hudson…  Read more

The Hudson Monash Precision Medicine Program hopes to significantly improve treatment for childhood cancer patients with the greatest unmet clinical need – those diagnosed with brain cancers and solid tumours. Launched today (February 7) ahead of International Childhood Cancer Day on February 15, the two year program is being established with a $1.3 million investment…  Read more

Dr Jason Cain has been awarded a Victorian Cancer Agency (VCA) Mid-Career Fellowship for his research to help tackle a rare and aggressive form of childhood cancer. Dr Cain was one of 14 successful VCA funding recipients announced by Acting Minister for Health, Martin Foley as part of a $7 million investment by the Victorian…  Read more

A cutting-edge CRISPR library containing more than 36,000 molecular scissors targeting every known gene in the human genome is realising the clinical potential of precision medicine research at Hudson Institute. Hudson Institute scientists now have access to the award-winning Merck/Sanger Arrayed Whole Genome CRISPR Library on-site at the Monash Health Translation Precinct. Associate Professor Ron…  Read more